Dobupride

This classification denotes an antipsychotic agent with the molecular formula C20H30ClN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FW0Z2U7O23, chemically known as 4-amino-2-butoxy-5-chloro-n-(1-(1,3-dioxolan-2-ylmethyl)-4-piperidyl)benzamide but generally known as dobupride, which bears US NIH Compound Identifier 65896. European Medicines Agency schedules Dobupride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06342MIG. The term DOBUPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). DOBUPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dobupride under HS 29349990 and SITC 51579. As of Q4 2014, DOBUPRIDE remains the US FDA Preferred Term for this commodity. Dobupride bears US NLM identifiers UMLS ID C0386741 and NCI Concept Code C65451. SMILES: CLC1CC(C(=O)NC2CCN(CC2)CC2OCCO2)C(OCCCC)CC1N.